arrow
F

Federica Deodato

Bambino Gesù
H指数:31
被引数:3,260

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2025 Consensus Clinical Management Guidelines for Niemann-Pick Disease Type C

2025年尼曼-皮克病C型的共识临床管理指南

2026-04-260
OAAI
Late-onset Pompe’s disease in pediatrics: results from an Italian national survey on 38 patients and proposal of a targeted diagnostic algorithm

儿科迟发性庞贝病:来自一项意大利全国性调查的38例患者的结果及针对性诊断算法的提出

2025-11-280
OAAI
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial

Arimoclomol在尼曼-皮克病C型中的长期疗效与安全性:NPC-002 48个月开放标签扩展试验2/3期的最终结果

2025-07-070
PRE
Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapy

VI型黏多糖贮积症患者经肝脏靶向基因治疗后多年度酶表达

MED
IF11.8
2024-11-010
PRE
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus
2023-03-075
PRE
Persistent effect of arimoclomol in patients with Niemann-Pick disease type C: 24-month results from an open-label extension of a pivotal phase 2/3 study

arimoclomol对C型niemann-pick病患者的持续作用: 关键2/3期研究的开放标签扩展的24个月结果

2022-02-010
PRE
Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study (vol 15, 328, 2020)
2021-06-011
OAAI
Persistent effect of arimoclomol in patients with Nuemann-Pick disease type C: 12-month results from an open-label extension of a pivotal phase 2/3 study
2021-02-010
PREAI
Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study
2020-11-2315
OAAI
Molecular Genetics of Niemann-Pick Type C Disease in Italy: An Update on 105 Patients and Description of 18 NPC1 Novel Variants

意大利C型niemann-pick疾病的分子遗传学: 105例患者的最新情况和18种NPC1新变异的描述

2020-03-0326
OAAI
Efficacy and safety of arimoclomol in patients with Niemann-Pick disease type C: Results from a double-blind, randomized placebo controlled trial with a novel treatment
2020-02-011
PREAI